Package Leaflet: Information for the User
Calmiox5 mg/gcream
hydrocortisone
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist.
Contents of the Package Leaflet
It is a topical medication that contains hydrocortisone as its active ingredient, a corticosteroid that relieves itching, inflammation, and skin irritation.
It is indicated for the temporary symptomatic relief of skin itching due to minor skin irritations that respond to corticosteroids, such as contact allergy to soaps, detergents, metals, insect bites, and nettles.
Do not use Calmiox
Warnings and Precautions
Consult your doctor or pharmacist before starting to use Calmiox.
Contact your doctor if you experience blurred vision or other visual disturbances.
Be careful with Calmiox
Children
Children and infants are especially sensitive, and it is more likely that the corticosteroid will produce side effects and pass into the body through the skin, having side effects in other areas of the body. In general, they require shorter treatments than adults.
Interference with Laboratory Tests
Calmiox may interfere with the results of diagnostic tests for adrenal function, which may decrease, as well as blood and urine glucose levels, which may increase if the medication has been absorbed.
Other Medications and Calmiox
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
Although no interactions have been described between Calmiox and other medications, it should not be used simultaneously with other preparations on the same area, unless prescribed by a doctor.
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
Calmiox should only be used during pregnancy if your doctor considers that the potential benefit of its use justifies the potential risk to the fetus.
Pregnant women should not use this medication on large areas of the skin, for prolonged periods, or use occlusive dressings.
Breastfeeding
Do not use Calmiox during breastfeeding unless your doctor advises you to do so.
Do not apply the medication to the breasts; do not let the child come into contact with treated areas.
Driving and Using Machines
No effects have been described that affect driving or using machines.
Calmiox contains benzoic acid (E-210), bronopol, and butylhydroxyanisole (E-320)
This medication contains 2 mg of benzoic acid (E-210) per gram of cream.
Benzoic acid may cause local irritation.
Benzoic acid may increase the risk of jaundice (yellowing of the skin and eyes) in newborns (up to 4 weeks of age).
This medication may cause local skin reactions (e.g., contact dermatitis) because it contains bronopol.
This medication may cause local skin reactions (such as contact dermatitis) or eye and mucous membrane irritation because it contains butylhydroxyanisole (E-320).
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
Topical use (external).
Use in Children
Wash your hands well after use.
Do not apply for more than 7 consecutive days without consulting a doctor, in any case.
If you use more Calmiox than you should
Prolonged use or application to large areas may increase the manifestation of its side effects.
In case of overdose or accidental ingestion, go immediately to a medical center or call the Toxicology Information Service, phone 91 562.04.20, indicating the medication and the amount ingested.
If you forget to use Calmiox
Do not use a double dose to make up for forgotten doses.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
At the administered doses, side effects are rare, usually occurring with use beyond 7 days and in very extensive areas or with occlusive dressings, disappearing when treatment is discontinued or the frequency of administration is reduced.
The following side effects may occur:
Rare Side Effects(may affect up to 1 in 1,000 people)
Very Rare Side Effects(may affect up to 1 in 10,000 people)
Side Effects of Unknown Frequency(cannot be estimated from available data):
In children with chronic treatments, isolated cases of increased intracranial pressure and adrenal suppression have been described, which manifest with growth retardation and weight gain; chronic therapy may interfere with child development.
Reporting Side Effects
If you experience any type of side effect, consult your doctor, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Store below 25°C.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown away through wastewater or household waste. Deposit the packaging and medications you no longer need at the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Calmiox Composition
Each gram of cream contains 5 mg of hydrocortisone (5mg/g).
Product Appearance and Package Contents
Calmiox is a cream, homogeneous white in color; it is presented in aluminum tubes with an interior epoxy resin coating and a polypropylene cap with a punch, containing 30 g and 50 g of cream.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Esteve Pharmaceuticals, S.A.
Passeig de la Zona Franca, 109
08038 Barcelona
Spain
Manufacturer
Kern Pharma, S.L.
Venus, 72 – Pol. Ind. Colón II
08228 Terrassa- Barcelona
Spain
Date of the Last Revision of this Package Leaflet:November 2022.
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/